Cargando…

PLOD2 Is a Prognostic Marker in Glioblastoma That Modulates the Immune Microenvironment and Tumor Progression

This study aimed to investigate the role of Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase 2 (PLOD2) in glioblastoma (GBM) pathophysiology. To this end, PLOD2 protein expression was assessed by immunohistochemistry in two independent cohorts of patients with primary GBM (n(1) = 204 and n(2) = 203,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kreße, Nina, Schröder, Hannah, Stein, Klaus-Peter, Wilkens, Ludwig, Mawrin, Christian, Sandalcioglu, Ibrahim Erol, Dumitru, Claudia Alexandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181500/ https://www.ncbi.nlm.nih.gov/pubmed/35682709 http://dx.doi.org/10.3390/ijms23116037

Ejemplares similares

Progesterone Receptor Membrane Component 1 (PGRMC1) Modulates Tumour Progression, the Immune Microenvironment and the Response to Therapy in Glioblastoma
por: Dumitru, Claudia Alexandra, et al.
Publicado: (2023)

Dynein Light Chain Protein Tctex1: A Novel Prognostic Marker and Molecular Mediator in Glioblastoma
por: Dumitru, Claudia Alexandra, et al.
Publicado: (2021)

Cannabinoids in Glioblastoma Therapy: New Applications for Old Drugs
por: Dumitru, Claudia A., et al.
Publicado: (2018)

Sex-specific clinicopathological significance of novel (Frizzled-7) and established (MGMT, IDH1) biomarkers in glioblastoma
por: Schiffgens, Salveena, et al.
Publicado: (2016)

PB1798: EVALUATION OF EXPRESSION OF PLODS FAMILY GENES (PLOD1, PLOD2, PLOD3) IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
por: Zaker, F., et al.
Publicado: (2022)

PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer
por: Li, Guang, et al.
Publicado: (2021)

Extravascular optical coherence tomography of cerebral vessel walls in vivo
por: Hartmann, Karl, et al.
Publicado: (2023)

Expression and Prognostic Role of PLOD1 in Malignant Glioma
por: Wang, Hao, et al.
Publicado: (2020)

Corrigendum to “PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer”
por: Li, Guang, et al.
Publicado: (2021)

Clinical Prognostic Value of the PLOD Gene Family in Lung Adenocarcinoma
por: Meng, Yiming, et al.
Publicado: (2022)

First in vivo visualization of the human subarachnoid space and brain cortex via optical coherence tomography
por: Hartmann, Karl, et al.
Publicado: (2019)

PLOD1 Is a Prognostic Biomarker and Mediator of Proliferation and Invasion in Osteosarcoma
por: Jiang, Haoli, et al.
Publicado: (2020)

Identification of PLOD Family Genes as Novel Prognostic Biomarkers for Hepatocellular Carcinoma
por: Yang, Bo, et al.
Publicado: (2020)

Brain biopsy in patients with CLIPPERS syndrome: why and when
por: Galazky, Imke, et al.
Publicado: (2022)

Aberrantly expressed PLOD1 promotes cancer aggressiveness in bladder cancer: a potential prognostic marker and therapeutic target
por: Yamada, Yasutaka, et al.
Publicado: (2019)

Theranostic applications of optical coherence tomography in neurosurgery?
por: Hartmann, Karl, et al.
Publicado: (2021)

Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma
por: Sun, Yawei, et al.
Publicado: (2021)

Roles of PLODs in Collagen Synthesis and Cancer Progression
por: Qi, Yifei, et al.
Publicado: (2018)

Hypoxia-induced PLOD1 overexpression contributes to the malignant phenotype of glioblastoma via NF-κB signaling
por: Wang, Zhenlin, et al.
Publicado: (2021)

SAA1 Expression as a Potential Prognostic Marker of the Tumor Microenvironment in Glioblastoma
por: Cao, Kangxi, et al.
Publicado: (2022)

PLODs: Novel prognostic biomarkers and potential immunotherapy targets for head and neck squamous cell carcinoma
por: Gong, Siming, et al.
Publicado: (2023)

Is the central nervous system enclosed by a mesothel?
por: Hartmann, Karl, et al.
Publicado: (2023)

Characterisation of the Drosophila procollagen lysyl hydroxylase, dPlod
por: Bunt, Stephanie, et al.
Publicado: (2011)

Integrated Profiling Identifies PLOD3 as a Potential Prognostic and Immunotherapy Relevant Biomarker in Colorectal Cancer
por: Shi, Junhong, et al.
Publicado: (2021)

Bioinformatic analysis of PLOD family member expression and prognostic value in non-small cell lung cancer
por: Qi, Qi, et al.
Publicado: (2021)

COLGALT2 is overexpressed in ovarian cancer and interacts with PLOD3
por: Guo, Ting, et al.
Publicado: (2021)

Overexpression of PLOD3 promotes tumor progression and poor prognosis in gliomas
por: Tsai, Chia-Kuang, et al.
Publicado: (2018)

PLOD3 promotes lung metastasis via regulation of STAT3
por: Baek, Jeong-Hwa, et al.
Publicado: (2018)

Overexpressing PLOD family genes predict poor prognosis in gastric cancer
por: Li, Shan-Shan, et al.
Publicado: (2020)

Overexpressing PLOD Family Genes Predict Poor Prognosis in Pancreatic Cancer
por: Zhang, Jing, et al.
Publicado: (2022)

Pan-Cancer Analyses Reveal Oncogenic and Immunological Role of PLOD2
por: Xu, Qiqi, et al.
Publicado: (2022)

Dysregulation of PLOD2 Promotes Tumor Metastasis and Invasion in Hepatocellular Carcinoma
por: Li, Keren, et al.
Publicado: (2023)

Surgical management of intradural spinal cord tumors in children and young adults: A single-center experience with 50 patients
por: Özkan, Neriman, et al.
Publicado: (2015)

Clinicopathological significances of PLOD2, epithelial–mesenchymal transition markers, and cancer stem cells in patients with esophageal squamous cell carcinoma
por: Gong, Xiaomeng, et al.
Publicado: (2022)

Differential expression of checkpoint markers in the normoxic and hypoxic microenvironment of glioblastomas
por: Petterson, Stine Asferg, et al.
Publicado: (2022)

PLOD2 regulated by transcription factor FOXA1 promotes metastasis in NSCLC
por: Du, Hongzhi, et al.
Publicado: (2017)

PLOD3 Is Associated with Immune Cell Infiltration and Genomic Instability in Colon Adenocarcinoma
por: Deng, Xianyu, et al.
Publicado: (2021)

Comprehensive Analysis of the Expression, Prognosis, and Biological Significance of PLOD Family in Bladder Cancer
por: Chen, Ru, et al.
Publicado: (2023)

Tissue Rings PLOD Out a Second Hit in Becker Muscular Dystrophy
por: Lee, Benjamin W., et al.
Publicado: (2023)

Identification of Regulatory Molecular “Hot Spots” for LH/PLOD Collagen Glycosyltransferase Activity
por: Mattoteia, Daiana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hr0futiik06vl79cv9hukvdb5a